NEW YORK (GenomeWeb News) – Zygem and Phthisis Diagnostics announced Thursday that they will collaborate on developing products for the detection of infectious pathogens in complex samples, such as stool, blood, and water.
The partnership will combine Zygem's enzymatic nucleic acid extraction technology with Phthisis' molecular diagnostic test expertise to develop products that can rapidly obtain high-quality DNA from infectious pathogens. The firms will initially focus on extracting pathogen DNA from stool.
"The ability of ZyGEM's unique temperature-controlled DNA extraction technology to work well with a wide range of sample types makes it suitable for use with challenging targets with high unmet need," Paul Kinnon, CEO of ZyGEM, said in a statement.
Financial and other terms of the partnership were not disclosed.